Equities

VG Life Sciences Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VGLS:PKC

VG Life Sciences Inc

Actions
  • Price (USD)0.0001
  • Today's Change0.00 / 0.00%
  • Shares traded640.25k
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of Feb 06 2026 19:39 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

VG Life Sciences Inc. is engaged in research and development of therapeutic and diagnostic pharmaceutical and medical products. The Company is focused on restructuring its business to pursue real estate acquisitions, development, and value-added development, resource mining and processing. The Company has not generated any revenue.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.30m
  • Incorporated1998
  • Employees7.00
  • Location
    VG Life Sciences IncPO Box 1020SOUTH PASADENA 91031United StatesUSA
  • Phone+1 (805) 879-9000
  • Fax+1 (302) 655-5049
  • Websitehttp://www.vglifesciences.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Virax Biolabs Group Ltd2.99k-5.64m1.68m19.00--0.2791--562.59-1.25-1.250.00070.81180.00040.53821.94157.37-74.60-111.16-77.64-133.38-1,515.05-4.50-189,095.00-7,009.4211.21-92.320.0959---95.95-42.409.98------
Carisma Therapeutics Inc52.63m8.04m1.91m46.000.2429--0.20030.03630.18810.18811.26-0.02082.17----1,144,174.0033.09-26.5851.48-30.35----15.28-169.12--------31.59--30.39---1.99--
Yubo International Biotech Ltd-20.00-1.23m1.96m18.00---------0.0099-0.00990.00-0.0098-0.00002-0.0005---1.11-105.87--------------0.2394-------99.43---48.55------
Clearmind Medicine Inc0.00-3.86m2.02m----0.1789-----30.64-30.640.007.540.00-------57.83-128.70-178.71-360.04------------0.5987------26.60------
ProtoKinetix, Inc.0.00-376.18k2.04m0.00--8.10-----0.001-0.0010.000.00060.00-------78.62-530.88-117.20-607.05------------0.00------12.34--18.34--
CDT Equity Inc0.00-20.70m2.06m6.00--0.3342-----473.79-473.790.003.350.00----0.00-358.56-----------------16.000.2881-------3,227.48------
VG Life Sciences Inc0.00-4.30m2.11m7.00---------0.0721-0.07210.00-0.04910.00-------384.41-294.08-----------587,591.90---1.70--------16.58------
Exousia Pro Inc0.00-854.02k2.15m0.00---------0.0642-0.06420.00-0.03180.00-------1,313,877.00-----------------1,816.06---------248.31------
Azitra Inc0.00-11.12m2.23m12.00--0.5115-----5.49-5.490.000.40660.00----0.00-157.91---203.88--------------0.1197---98.91--29.05------
Mosaic Immunoengineering Inc0.00-671.75k2.35m2.00---------0.0928-0.09280.00-1.010.00----0.00-1,410.50-----------------7.37--------8.56------
Cardio Diagnostics Holdings Inc15.79k-6.55m2.36m13.00--0.2796--149.18-4.07-4.070.00974.610.0024--1.251,214.62-98.75---104.31-------41,495.31-----440.220.00--104.39---0.079------
Purminds Enterprises Inc0.00-77.46k2.36m0.00--0.0654-----0.1832-0.18320.000.76460.00-------26.19-620.48-66.38-------------6.290.00-------13.29------
Bluejay Diagnostics Inc0.00-20.07m2.40m7.00--0.3762-----134.42-134.420.009.010.00----0.00-103.46-70.71-124.04-82.92-------12,694.84----0.0028-------110.38--119.51--
Bone Biologics Corp0.00-3.95m2.51m2.00--0.4177-----7.30-7.300.003.350.00----0.00-75.76-86.22-80.46-561.06------------0.00------18.15------
Propanc Biopharma Inc0.00-63.41m2.54m1.00--0.1761-----45.47-45.470.001.080.00----0.00-702.98---1,223.40-------------56.990.0422-------2,826.43------
Data as of Feb 06 2026. Currency figures normalised to VG Life Sciences Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.